Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    New release note 'Revision: v3.6.3' was added to the study record history, while the prior 'Revision: v3.6.2' entry was removed. This reflects a site-wide update being logged in the history and does not alter the study data or records.
    Difference
    0.1%
    Check dated 2026-07-05T14:23:50.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating an update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-06-28T08:32:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New navigation links 'Check who can join' and 'Find Contact Information' were added to the page, improving quick access to enrollment and contact details. The release tag now shows 'Revision: v3.6.0' and the previous 'Revision: v3.5.5' tag has been removed.
    Difference
    0.4%
    Check dated 2026-06-13T17:51:22.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous revision label (v3.5.4) on the study history page, signaling a new version of the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-06T14:20:20.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated to v3.5.4, indicating a new version of the study record history. This update does not change the underlying study data or trial details.
    Difference
    0.1%
    Check dated 2026-05-15T23:59:24.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number updates from **v3.5.2** to **v3.5.3**, indicating a site release without changing the trial record text.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:02.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.